000 | 02005 a2200625 4500 | ||
---|---|---|---|
005 | 20250518031231.0 | ||
264 | 0 | _c20200128 | |
008 | 202001s 0 0 eng d | ||
022 | _a1096-8652 | ||
024 | 7 |
_a10.1002/ajh.25469 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeung, Garret M K | |
245 | 0 | 0 |
_aDistinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations. _h[electronic resource] |
260 |
_bAmerican journal of hematology _c06 2019 |
||
300 |
_a650-657 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAbnormal Karyotype |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aChromosomes, Human _xgenetics |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMonosomy |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
700 | 1 | _aZhang, Chunxiao | |
700 | 1 | _aNg, Nelson K L | |
700 | 1 | _aYang, Ning | |
700 | 1 | _aLam, Stephen S Y | |
700 | 1 | _aAu, Chun H | |
700 | 1 | _aChan, Tsun L | |
700 | 1 | _aMa, Edmond S K | |
700 | 1 | _aTsui, Sze P | |
700 | 1 | _aIp, Ho W | |
700 | 1 | _aSo, Jason C C | |
700 | 1 | _aNg, Margaret H L | |
700 | 1 | _aCheng, Kelvin C K | |
700 | 1 | _aWong, Kit F | |
700 | 1 | _aSiu, Lisa L P | |
700 | 1 | _aYip, Sze F | |
700 | 1 | _aLin, Shek Y | |
700 | 1 | _aLau, June S M | |
700 | 1 | _aLuk, Tsan H | |
700 | 1 | _aLee, Harold K K | |
700 | 1 | _aLau, Chi K | |
700 | 1 | _aKho, Bonnie | |
700 | 1 | _aKwong, Yok L | |
700 | 1 | _aLeung, Anskar Y H | |
773 | 0 |
_tAmerican journal of hematology _gvol. 94 _gno. 6 _gp. 650-657 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.25469 _zAvailable from publisher's website |
999 |
_c29506196 _d29506196 |